Analysis of Chromosomal Breakpoints
Chromosome Breakpoints info
Total Breakpoints: 23167
|
PubMed reference(s) |
Type of Aberration | ChiPPI network |
UniProtKB fusion |
RNAseq, evidence |
Cancer type & Drug Therapy (DT) |
Description of Diseases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |||||||||||
|
1532241 [1]Mitelman[2] 23141 |
 |
inv(1)(q21q31) | 
|
 |
|
|  Adenocarcinoma (CA ad). | ||||||||||||
|
 |
t(1;14)(q21;q32) |
|
|
|
|
| ||||||||||||
|
1406658 [1]Mitelman[2] 23143 |
|
t(8;14)(q24;q11) |
| TRD
| PVT1
|  Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL). | |||||||||||||
|
1402676 ChiTaRS 23144 |
|
t(1;3)(p32-34;p21) |
|
|
| T-cell Acute lymphoblastic leukemia (T-ALL). | |||||||||||||
|
|
t(1;3)(p32;p21) |
|
|
|
| |||||||||||||
|
 |
del(1)(p33) |
|
|
| Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL). | |||||||||||||
|
|
t(11;14)(q23;q32) |
|
|
|
|
| ||||||||||||
|
|
t(17;19)(q22;p13) |
|
|
|
| |||||||||||||
|
|
t(9;14)(p13;q32) |
|
|
|
|
| ||||||||||||
|
|
del(9)(q34q34) |
|
|
|
| |||||||||||||
D015179
B-cell malignancies.